...
首页> 外文期刊>Veterinary Ophthalmology >Mucoadhesive chitosan films as a potential ocular delivery system for ofloxacin: preliminary in vitro studies.
【24h】

Mucoadhesive chitosan films as a potential ocular delivery system for ofloxacin: preliminary in vitro studies.

机译:粘膜黏着性壳聚糖膜可作为氧氟沙星的潜在眼部递送系统:初步的体外研究。

获取原文
获取原文并翻译 | 示例

摘要

Objective: The objective of the study is to evaluate the physical properties, in vitro release profile, and antibacterial efficiency of chitosan films prepared with ofloxacin. Procedure: Mucoadhesive films were prepared by means of a casting and solvent evaporation technique performed in a 2 wt% acetic acid solution and distilled water. Physical properties were characterized by release and swelling studies, differential scanning calorimetry (DSC) analysis, and attenuated total reflectance Fourier transformed infrared spectroscopy (ATR-FTIR) analysis. The in vitro evaluation of the films was performed by inhibiting Staphylococcus aureus and Pseudomonas aeruginosa through activity studies. Results: Circular ofloxacin-loaded chitosan-developed films with 0.3 mg of drug weighed 7 mg were 110 micro m thick and 5 mm in diameter. The DSC curve of ofloxacin-loaded chitosan films suggests an amorphous dispersion of ofloxacin within these films. ATR-FTIR analysis showed that ofloxacin is indeed present in the matrix film. The drug was released in vitro over a 1-h period. No statistical difference could be observed between the ofloxacin-loaded chitosan films and sterile disk soaked for 1 min in 0.3% commercial ofloxacin ophthalmic solution for S. aureus and P. aeruginosa (P=0.1686, P=0.1172, respectively). The films presented a significantly larger mean bacterial inhibition zone of S. aureus than did the commercial ciprofloxacin control disk (P=0.0002) and a significantly larger mean bacterial kill zone of P. aeruginosa than did the commercial enrofloxacin control disk (P<0.0001). Conclusions: Ofloxacin was successively incorporated onto chitosan films and was not inactivated during the process of manufacturing, thus preserving antibacterial proprieties.
机译:目的:本研究的目的是评估氧氟沙星制备的壳聚糖膜的物理性质,体外释放曲线和抗菌效果。步骤:通过在2 wt%的乙酸溶液和蒸馏水中进行的流延和溶剂蒸发技术制备粘膜粘膜。通过释放和溶胀研究,差示扫描量热法(DSC)分析和衰减全反射傅里叶变换红外光谱(ATR-FTIR)分析来表征物理性能。通过活性研究,通过抑制金黄色葡萄球菌和铜绿假单胞菌来进行膜的体外评估。结果:载有氧氟沙星的壳聚糖显影的圆形薄膜(重7 mg,重0.3 mg)厚110微米,直径5毫米。氧氟沙星负载的壳聚糖膜的DSC曲线表明氧氟沙星在这些膜中的无定形分散。 ATR-FTIR分析表明,氧氟沙星确实存在于基质膜中。该药物在1小时内在体外释放。载有氧氟沙星的壳聚糖薄膜与在0.3%金黄色葡萄球菌和铜绿假单胞菌的0.3%商业氧氟沙星滴眼液中浸泡1分钟的无菌盘之间没有统计学差异(分别为P = 0.1686,P = 0.1172)。薄膜呈现的金黄色葡萄球菌的平均抑菌圈数比市售环丙沙星对照盘大(P = 0.0002),铜绿假单胞菌的平均细菌杀灭区比市售的恩诺沙星对照盘大(P <0.0001) 。结论:氧氟沙星先后被掺入壳聚糖膜中,并且在生产过程中未被灭活,从而保留了抗菌性能。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号